Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:42 AM
Ignite Modification Date:
2025-12-25 @ 2:42 AM
NCT ID:
NCT01533233
Eligibility Criteria:
Inclusion Criteria:
1. Non-small cell lung cancer with clinical staging of I or II for whom thoracoscopic lobectomy is feasible.
2. Age between 25 and 80 years old
3. Tumor size \< 5 cm without chest wall, diaphragm, or main bronchus invasion
4. Predicted FEV 1.0 \> 60% or FEV1.0 \> 1.5L
5. Organ Function Requirements:
* Adequate hematological function (ANC \> 1.5 x 109/L, platelets \> 100 x 109/L)
* PT, PTT\<1.5X
6. Written inform consent
Exclusion Criteria:
1. Failed thoracic epidural catheter insertion
2. A history of previous epidural catheter insertion or ipsilateral thoracic operation
3. Signs of intrapleural adhesions
4. Pregnant or lactation female
5. ASA score greater than 3
6. Unfavorable airway or spinal anatomy judged by anesthesiologist
7. Sleep apnea
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
25 Years
Maximum Age:
80 Years
Study:
NCT01533233
Study Brief:
Protocol Section:
NCT01533233